David R. Silk david.silk.wg10@wharton.upenn.edu


Princeton University, Princeton, NJ B.A., Cum Laude, History, 2002


Ashley Elizabeth Smith


ashley.smith.wg10@wharon.upenn.edu Duke University, Durham, NC B.A., Public Policy Studies, Health Policy, 2003


Spencer A. Smith


spencer.smith.wg10@wharton.upenn.edu Princeton University, Princeton, NJ A.B., Magna Cum Laude, Economics, 2004


To leverage my reimbursement expertise in a strategic marketing or business development role in the biopharmaceutical sector.


Johnson & Johnson, Raritan, NJ MBA Intern, Global Strategic Marketing- Oncology, Summer 2009


Revised forecasting methodology to more accurately capture emerging market oncology sales. Revision formed basis of cross-company adjust- ments. Created detailed physician decision-making model for Velcade® (bortezomib) launch strategy. Designed global oncology growth model to inform global acquisition and licensing targets.


Avalere Health, LLC, Washington, DC Manager, Senior Associate, Associate, 2004-2008


Provided strategic and tactical guidance on reimbursement, product launch, and commercialization strategies for cardiovascular, neurologic, orthopedic and oncology products. Managed reimbursement and payment strategies and tactics for $1.1B medical device company. Co-founded new practice group focused on evidence-based medicine and quality. Group grew to 23 FTEs and generated over $4M. Coordinated coverage and payment for 1,040-patient, $250M+, multi- center clinical trial. Designed payment analysis models that generated over $200,000 in new revenue.


The Lewin Group, Falls Church, VA Research Analyst I/II, 2002-2004 Designed cardiac “Centers of Excellence” program for major insurer that allowed client to retain largest customer. Created cost reduction strategy that saved 588 bed urban hospital $26M.


Corporate or international business development or strategic marketing within a progressive health care company.


Medtronic, Inc. Minneapolis, MN Strategy Summer Associate, Summer 2009 Contributed towards development of long term strategy for Medtronic’s largest business unit. Led evaluation and communication of European customer segment need around critical strategic initiative. Presented strategic implications to numerous leadership teams and incorporated into board recommendations.


The Chartis Group, New York, NY Consultant, Associate Consultant, Analyst, 2005-2008


Assisted leading health systems and hospitals in developing and imple- menting strategic and operational improvements. Developed five year strategic growth plan for reputable health system, modeled volume and financial implications. Executed comprehensive analyses of strategic and operational opportunities, including innovative model assessing physician capacity and utilization. Co-led Chartis junior member group and initiative improving on-boarding process for new hires. Conducted recruiting interviews contributing to 20% firm growth.


The Lewin Group, Falls Church, VA Research Associate, 2003-2005 Generated AHA Trendwatch issue briefs on healthcare trends, including growth of specialty hospitals and economic costs incurred by hospitals. Reports distributed to hospital execu- tives and politicians and cited within Health Affairs. Conducted comprehensive scientific literature analyses for AHRQ.


An opportunity to invest in healthcare companies.


Auxilium Pharmaceuticals, Malvern, PA Summer Associate, Business Development, Summer 2009


Led the out-licensing process for an early-stage asset by contacting partners, writing the confidential information package, and managing the diligence process. Analyzed licensing comps and built financial model to estimate the value of a territory-specific deal for Xiaflex™ (Auxilium’s lead compound).


Aisling Capital, New York, NY Analyst, 2006-2008


Executed 8 private equity investments as the lead analyst; primary responsi- bilities included meeting with senior management of prospective companies, building financial models, conducting due diligence, structuring investment vehicles, and presenting investment opportunities to the partnership.


McKinsey & Company, Florham Park, NJ Business Analyst, 2004-2006 Worked closely with clients’ senior management as a member of McKinsey’s Pharmaceutical and Medical Products practice; primary responsibilities included building valuation models, developing in-depth industry perspectives, structuring client recommendations, and presenting to clients.


23


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40